TG Therapeutics (TGTX)
TG Therapeutics (TGTX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- TGTX last traded at $63.21 on 2026-11-20, -2.57% for the session.
- TG Therapeutics: market cap $9.55B, P/E 90.1, revenue $897.76M over the last four quarters.
- Over the past year TGTX returned 108.41%, with a year-to-date return of 112.04%.